DE3852963D1 - Kristallines menschliches Proinsulin und Verfahren zu dessen Herstellung. - Google Patents

Kristallines menschliches Proinsulin und Verfahren zu dessen Herstellung.

Info

Publication number
DE3852963D1
DE3852963D1 DE3852963T DE3852963T DE3852963D1 DE 3852963 D1 DE3852963 D1 DE 3852963D1 DE 3852963 T DE3852963 T DE 3852963T DE 3852963 T DE3852963 T DE 3852963T DE 3852963 D1 DE3852963 D1 DE 3852963D1
Authority
DE
Germany
Prior art keywords
production
human proinsulin
crystalline human
crystalline
proinsulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3852963T
Other languages
English (en)
Other versions
DE3852963T2 (de
Inventor
Richard Lee Jackson
Eddie Herman Massey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of DE3852963D1 publication Critical patent/DE3852963D1/de
Application granted granted Critical
Publication of DE3852963T2 publication Critical patent/DE3852963T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE3852963T 1987-04-23 1988-04-20 Kristallines menschliches Proinsulin und Verfahren zu dessen Herstellung. Expired - Fee Related DE3852963T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/041,498 US4764592A (en) 1987-04-23 1987-04-23 Crystalline human proinsulin and process for its production

Publications (2)

Publication Number Publication Date
DE3852963D1 true DE3852963D1 (de) 1995-03-23
DE3852963T2 DE3852963T2 (de) 1995-06-29

Family

ID=21916831

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3852963T Expired - Fee Related DE3852963T2 (de) 1987-04-23 1988-04-20 Kristallines menschliches Proinsulin und Verfahren zu dessen Herstellung.

Country Status (21)

Country Link
US (1) US4764592A (de)
EP (1) EP0288273B1 (de)
JP (1) JP2602529B2 (de)
KR (1) KR0126477B1 (de)
CN (1) CN1030988C (de)
AR (1) AR244242A1 (de)
AT (1) ATE118220T1 (de)
AU (1) AU609798B2 (de)
CA (1) CA1339045C (de)
DE (1) DE3852963T2 (de)
DK (1) DK210188A (de)
ES (1) ES2068826T3 (de)
GR (1) GR3015662T3 (de)
HU (1) HU202555B (de)
IE (1) IE65952B1 (de)
IL (1) IL86094A (de)
MX (1) MX166069B (de)
NZ (1) NZ224281A (de)
PH (1) PH24261A (de)
PT (1) PT87265B (de)
ZA (1) ZA882714B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH23446A (en) * 1986-10-20 1989-08-07 Novo Industri As Peptide preparations
DE58906966D1 (de) * 1988-06-23 1994-03-24 Hoechst Ag Mini-Proinsulin, seine Herstellung und Verwendung.
US5130298A (en) * 1989-05-16 1992-07-14 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
DK168790D0 (de) * 1990-07-13 1990-07-13 Novo Nordisk As
US5504188A (en) * 1994-06-16 1996-04-02 Eli Lilly And Company Preparation of stable zinc insulin analog crystals
US5631347A (en) * 1995-06-07 1997-05-20 Eli Lilly And Company Reducing gelation of a fatty acid-acylated protein
CN105801686B (zh) 2004-07-19 2020-04-07 比奥孔有限公司 胰岛素-低聚物共轭物、制剂及其用途
CN101389650B (zh) 2005-12-28 2012-10-10 诺沃-诺迪斯克有限公司 包含酰化胰岛素和锌的组合物以及制备所述组合物的方法
EP2203181B1 (de) 2007-10-16 2018-02-14 Biocon Limited Oral zu verabreichende feste pharmazeutische zusammensetzung und verfahren dafür
WO2011141407A1 (en) * 2010-05-10 2011-11-17 Novo Nordisk A/S Process for the preparation of insulin-zinc complexes
KR20140007377A (ko) * 2011-02-01 2014-01-17 노보 노르디스크 에이/에스 인슐린의 정제
CN102219851B (zh) 2011-05-09 2012-05-30 甘李药业有限公司 甘精胰岛素结晶的制备方法
CN109957001B (zh) * 2017-12-26 2022-11-18 甘李药业股份有限公司 甘赖脯胰岛素结晶的制备方法
CN111304271A (zh) * 2020-02-28 2020-06-19 东莞市东阳光生物药研发有限公司 一种含脂肪酸侧链的胰岛素类似物的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE515508A (de) *
DE132863C (de) * 1901-07-11
US2143590A (en) * 1936-09-26 1939-01-10 Univ Alberta Insulin preparation and process of producing crystals of insulin
US2174862A (en) * 1938-12-30 1939-10-03 Frederick Stearns & Company Process of producing crystalline insulin
US2626228A (en) * 1945-05-17 1953-01-20 Novo Terapeutisk Labor As Method of producing crystalline insulin
US2663666A (en) * 1949-03-31 1953-12-22 Organon Process of preparing crystalline insulin from acid alcoholic extracts of pancreas glands
US2836542A (en) * 1952-02-13 1958-05-27 Novo Terapeutisk Labor As Process of production of crystalline insulin
DK78069C (da) * 1952-06-23 1954-09-06 Novo Terapeutisk Labor As Fremgangsmåde til fremstilling af krystallinsk insulin.
GB786635A (en) * 1953-08-19 1957-11-20 Roskilde Medical Company Ltd R Method for the production of insulin with increased zinc content
US3102077A (en) * 1953-08-19 1963-08-27 Christensen Henry Marinus Preparation of insulin containing 2.75 to 8 percent zinc content
US4430266A (en) * 1980-11-28 1984-02-07 Eli Lilly And Company Process for producing an insulin precursor
US4654324A (en) * 1981-08-27 1987-03-31 Eli Lilly And Company Human proinsulin pharmaceutical formulations
DE3326472A1 (de) * 1983-07-22 1985-02-14 Hoechst Ag, 6230 Frankfurt Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
US4616078A (en) * 1985-04-08 1986-10-07 Eli Lilly And Company Process for purifying proinsulin-like materials

Also Published As

Publication number Publication date
IL86094A0 (en) 1988-09-30
NZ224281A (en) 1990-06-26
PT87265B (pt) 1992-08-31
PT87265A (pt) 1988-05-01
KR0126477B1 (ko) 1997-12-19
ZA882714B (en) 1989-12-27
CN88102311A (zh) 1988-11-09
JP2602529B2 (ja) 1997-04-23
ES2068826T3 (es) 1995-05-01
EP0288273A3 (en) 1990-08-08
PH24261A (en) 1990-05-04
EP0288273A2 (de) 1988-10-26
CA1339045C (en) 1997-04-01
KR880012642A (ko) 1988-11-28
HU202555B (en) 1991-03-28
AR244242A1 (es) 1993-10-29
HUT46705A (en) 1988-11-28
IL86094A (en) 1993-06-10
DE3852963T2 (de) 1995-06-29
DK210188D0 (da) 1988-04-18
US4764592A (en) 1988-08-16
EP0288273B1 (de) 1995-02-08
IE65952B1 (en) 1995-11-29
MX166069B (es) 1992-12-17
IE881183L (en) 1988-10-23
DK210188A (da) 1989-01-03
ATE118220T1 (de) 1995-02-15
AU609798B2 (en) 1991-05-09
GR3015662T3 (en) 1995-07-31
CN1030988C (zh) 1996-02-14
JPS63280100A (ja) 1988-11-17
AU1474788A (en) 1988-11-10

Similar Documents

Publication Publication Date Title
DE3850800D1 (de) Supraleitendes Material und Verfahren zu dessen Herstellung.
DE3879320D1 (de) Copolyester und verfahren zu dessen herstellung.
DE3783007D1 (de) 9-alpha-hydroxysteroide, verfahren zu ihrer herstellung und verfahren zur herstellung der entsprechenden 9(11)-dehydro-derivate.
DE3751812D1 (de) Kristallines Blockcopolymer und Verfahren zu dessen Herstellung
DE3780560D1 (de) Fuehler und verfahren zu dessen herstellung.
DE68919100D1 (de) Piezoelektrischer Summer und Verfahren zu dessen Herstellung.
DE3866744D1 (de) Copolyaether-imide und verfahren zu ihrer herstellung.
DE3874275D1 (de) Kollektoren und verfahren zu ihrer herstellung und ihrer verwendung.
DE3878340D1 (de) Kristalliner l-carnosin-zink-komplex und dessen herstellung.
DE3861531D1 (de) Uhrengehaeuse, einheit zu dessen herstellung und verfahren zum bauen dieser einheit.
DE3689932D1 (de) Amorfes Alumosilikat und Verfahren zu dessen Herstellung.
DE3852963D1 (de) Kristallines menschliches Proinsulin und Verfahren zu dessen Herstellung.
DE3878475D1 (de) Organopolysiloxanemulsion und verfahren zu ihrer herstellung.
DE3884069D1 (de) Polysilazan und Verfahren zu dessen Herstellung.
DE3852150D1 (de) Polysilazan und Verfahren zu dessen Herstellung.
DE68924533D1 (de) Knochenwachstumsmatrix und verfahren zu ihrer herstellung.
DE3879536D1 (de) Supraleitender keramischer film und verfahren zu dessen herstellung.
DE3776920D1 (de) Waessriges praeparat und verfahren zu dessen herstellung.
DE3878880D1 (de) Metall-keramik-verbindung und verfahren zu ihrer herstellung.
DE3860980D1 (de) Uhr und verfahren zu deren herstellung.
DE3751753D1 (de) Kreuzstrom-filtrationsapparat und verfahren zu dessen herstellung
DE3880287D1 (de) Chlortrifluoraethylen-telomere und verfahren zu ihrer herstellung.
DE3879335D1 (de) Trifluorbenzolverbindungen und verfahren zu ihrer herstellung.
DE3867918D1 (de) Wachstumspromotor fuer bifidobacterium-arten, prozess zu dessen herstellung und verfahren fuer dessen anwendung.
DE3779946D1 (de) Antibiotikum a42125 und verfahren zu dessen herstellung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee